- Details
- Written by White House
- Category: News
Washington, DC - By the authority vested in me as President by the Constitution and the laws of the United States of America, and in order to enhance public safety and support the well-ordered administration of justice, it is hereby ordered as follows:
- Details
- Written by Office of National Drug Control Policy
- Category: News
Washington, DC - Today, the White House Office of National Drug Control Policy (ONDCP) recognized members of Colombia’s military and law enforcement who have been severely wounded in the fight against drug trafficking and terrorism.
- Details
- Written by IVN
- Category: News
Washington, DC - Today, the President’s Commission on White House Fellows announces the appointment of the 2019-2020 class of White House Fellows. The highly regarded White House Fellowship provides professionals from diverse backgrounds an opportunity to engage in public service for one year by serving in various roles in the Federal Government.
- Details
- Written by White House
- Category: News
Washington, DC - "Today, I stand before you, as the President of the United States, to tell you that my Administration will always honor, cherish, and support the men and women in blue." ~ President Donald J. Trump
- Details
- Written by IVN
- Category: News
Washington, DC - Continuing its work to protect older Americans from fraud, the Federal Trade Commission sued a publisher called Agora Financial, LLC, alleging that it tricks seniors into buying books, newsletters, and other publications that falsely promise a cure for type 2 diabetes or promote a phony plan to help them cash in on a government-affiliated check program.
- Details
- Written by Council of Economic Advisers
- Category: News
Washington, DC - October 26 marked National Prescription Drug Take Back Day, which provided Americans an opportunity to prevent drug misuse and theft by ridding their homes of potentially dangerous expired, unused, and unwanted prescription drugs. One of the most tangible examples of the dangers of misusing prescription drugs comes from the opioid crisis, which the Council of Economic Advisers (CEA) estimates cost $696 billion in 2018—or 3.4 percent of GDP—and more than $2.5 trillion for the four-year period from 2015 to 2018. These massive costs point to the nationwide economic destruction from America’s very human “crisis next door.”
Subcategories
Page 441 of 1259
- You are here:
-
Home
-
News
-
World News
- News